The largest database of trusted experimental protocols

Tpmpa

Manufactured by Merck Group

TPMPA is a laboratory equipment product manufactured by Merck Group. It serves as a core functional unit for various scientific applications. The details of its intended use or specific applications are not provided in this factual description.

Automatically generated - may contain errors

3 protocols using tpmpa

1

Perinatal Mouse Brain Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Perinatal mice are hypothermically anesthetized for 2–3 minutes before surgery, and kept cold for the brief period during surgical injection. Pulled glass micropipettes (1B150F-4; World Precision Instruments) were loaded with AAV-Syn-GCaMP6f or AAV-Syn-jRCaMP1b and then 1–2uL was pressure injected into each ocular vitreous or transverse sinus at P0-P1. Mice are then placed on a temperature-controlled heat pad after surgery and returned to their mothers upon recovery from anesthesia. After retinal injections, we waited 4–5 days for virus to transfect and fill retinal ganglion cell axons. For acute eye injections, either (1) 0.5–1 µl of 10 µM (±)-epibatidine dihydrochloride hydrate (Sigma no. E1145) dissolved in saline, or (2) a cocktail of 1 mM AP5 (Tocris) and 200 µM NBQX (Tocris), or (3) a cocktail of 500 µM 1,2,5,6-Tetrahydropyridine-4-yl-methylphosphinic acid (TPMPA, Sigma), 50 µM gabazine (Tocris), and 5 uM strychnine (Sigma) was pressure injected using a glass micropette inserted into the vitreous.
+ Open protocol
+ Expand
2

Direct vs. Indirect RGC Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To distinguish between direct stimulation of RGCs and indirect stimulation of
RGCs through the inner retina, INL to RGC transmission was blocked using excitatory and
inhibitory blockers. If responses are still present after blocking synaptic transmission,
this would indicate RGCs are being directly stimulated. If no responses remain after
blocking synaptic transmission, we can conclude that the INL is stimulated without
involving RGCs directly. We compared untreated PVA-evoked responses to those evoked after
intravitreal injection of saline (2.5μl) and to PVA-stimulation 3–5 min
after intravitreal injection of synaptic blockers (2.5μl). The synaptic blocker
cocktail consisted of two glutamate receptor antagonists (DAP-5 (50 μM) and CNQX
(10 μM), Sigma-Aldrich) and three inhibitory receptor antagonists (picrotoxin 10
μM, TPMPA 50 μM, strychnine 10 μM; Sigma-Aldrich) dissolved in
lactated Ringer’s solution. These concentrations represent the final
concentrations in the vitreous and were calculated using the estimated vitreal volume for
the rat eye (52.5 μl; Sha and Kwong 2006 ).
A complete block of synaptic signaling was characterized by a complete or nearly complete
decline in spontaneous activity within 5 minutes of synaptic blocker injection.
+ Open protocol
+ Expand
3

Retinal Pharmacology: Modulating Inhibitory Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All applied pharmacological drugs were prepared freshly from stock solutions for each experiment. The drugs were diluted in oxygenated Ames’ medium (see above) and bath-applied to the retina. Recordings were resumed after 10–15 min. The following concentration of the drugs were used: either 5 or 10 µM GABAzine (SR95531; Sigma-Aldrich), 50 µM TPMPA ((1,2,5,6-tetrahydro-pyridine-4-yl)methylphosphinic acid; Sigma-Aldrich), either 0.5 or 1 µM of strychnine (Sigma-Aldrich), and 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Sigma-Aldrich). Before administration of HEPES to the retina, the pH of the Ames’ solution was adjusted to 7.4.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!